×

1. Chang HW, Kim SH, Kim KH, Kim YJ. Combined anti-calcification treatment of bovine pericardium with amino compounds and solvents. Interact CardioVasc Thorac Surg 2011;12(6):903-907.

2. Chang HW, Kim KH, Kim JS, Kim KH, Kim YJ. Relationship between morphologic features of myocardial tissue and left ventricular function in patients with aortic valve disease and left ventricular hypertrophy. J Heart Valve Dis 2013;22(4):476-483.

3. Chang HW, Kim KH, Hwang HY, Kim JS. Role of mitral valve repair in infective endocarditis. J Heart Valve Dis 2014;23(3):350-359.

4. Chang HW, Nam J, Cho JH, Lee JR, Kim YJ, Kim WH. Five-year experience with mini-volume priming in infants ≤5 kg: Safety of significantly smaller transfusion volumes. Artif organs 2014;38(1):78-87.

5. Chang HW, Jeong DS, Cho YH et al. Tricuspid valve replacement vs. Repair in severe tricuspid regurgitation. Circ J 2017;81(3):330-338.

6. Chang HW, Jeong DS, Cho YH et al. Replacement of calcified ascending aorta in patients undergoing aortic valve replacement. J Thorac Dis 2017;9(11):4424-4433.

7. Chang HW, Hwang HY, Seo JW, Kim KB. Lower versus upper leg saphenous vein composite grafts based on the left internal thoracic artery: A randomized study. J Thorac Cardiovasc Surg 2018;156(3):986-94 e2.

8. Chang HW, Kim HJ, Yoo JS, Kim DJ, Cho KR. Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting. J Clin Med. 2019;8(1):104.

9. Choi W, Chang HW, Kang SH, Yoon CH, Cho YS, Youn TJ, et al. Comparison of Minimally Invasive Direct Coronary Artery Bypass and Percutaneous Coronary Intervention Using Second-Generation Drug-Eluting Stents for Coronary Artery Disease- Propensity Score-Matched Analysis. Circ J. 2019. (advance publication)

10. Kang J, Kim JH, Lee KH, Lee WS, Chang HW, Kim JS, et al. Risk Factor Analysis of Extended Opioid Use after Coronary Artery Bypass Grafting: A Clinical Data Warehouse-Based Study. Healthc Inform Res. 2019;25(2):124-30.

11. Chang HW, Kim WS, Ahn JH, Carriere KC, Jeong DS, Cho YH, et al. Late clinical outcomes of aortic valve replacement with Carpentier-Edwards pericardial valves. J Thorac Dis. 2019;11(12):5372-81.

1. Kim WH, Chang HW, Yang SW, Cho JH, Lee KH, Baek IH, et al. Minimized Priming Volume for Open Heart Surgery in Neonates and Infants. Korean J Thorac Cardiovasc Surg 2009;42(4):418-25.

2. Kim JS, Lee JH, Chang HW, Kim KH. Surgical outcomes of cox-maze iv procedure using bipolar irrigated radiofrequency ablation and cryothermy in valvular heart disease. Korean J Thorac Cardiovasc Surg 2011;44(1):18-24.

3. Hwang HY, Chang HW, Jeong DS, Ahn H. De vega annuloplasty for functional tricupsid regurgitation: Concept of tricuspid valve orifice index to optimize tricuspid valve annular reduction. J Korean Med Sci 2013;28(12):1756-1761.

4. Jeong DS, Chang HW, Kim KH, Ahn H. Impact of patient-prosthesis mismatch in the aortic position: Twenty-year experience with korean patients. J Heart Valve Dis 2013;22(1):56-63.

5. Song JJ, Choi IJ, Chang H et al. Pediatric tracheostomy revisited: A nine-year experience using horizontal intercartilaginous incision. Laryngoscope 2015;125(2):485-492.

6. Kim YH, Kim JS, Choi JW et al. Clinical implication of aortic wall biopsy in aortic valve disease with bicuspid valve pathology. Korean J Thorac Cardiovasc Surg 2016;49(6):443-450.

7. Choi JW, Kim KH, Chang HW, Jang MJ, Kim SH, Yeom SY, et al. Long-term results of annuloplasty in trivial-to-mild functional tricuspid regurgitation during mitral valve replacement: should we perform annuloplastyon the tricuspid valve or leave it alone? Eur J Cardiothorac Surg 2018;53(4):756-63.

8. Lee H, Cho YH, Chang HW, Yang JH, Cho JH, Sung K, et al. The Outcome of Extracorporeal Life Support After General Thoracic Surgery: Timing of Application. Ann Thorac Surg 2017;104(2):450-7.

9. Cho S, Kim WH, Choi ES, Kwak JG, Chang HW, Hyun K, et al. Outcomes after extracardiac Fontan procedure with a 16-mm polytetrafluoroethylene conduit. Eur J Cardiothorac Surg 2018;53(1):269-75.